Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot study
Open Access
- 23 February 2005
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 42 (5) , 632-638
- https://doi.org/10.1016/j.jhep.2004.10.031
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Efficacy and safety of rituximab in type II mixed cryoglobulinemiaBlood, 2003
- Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon α with an anti-CD20Blood, 2003
- Optimal therapy of hepatitis CHepatology, 2002
- Hepatitis C virus infection and vasculitis: Implications of antiviral and immunosuppressive therapiesArthritis & Rheumatism, 2002
- Peginterferon-??-2a (40kD)Drugs, 2001
- HCV-associated autoimmune haemolytic anaemia do to warm-reactingantibodies: Evidence of B-cell monoclonalityJournal of Hepatology, 2000
- Acute exacerbation of vasculitis during interferon-α therapy for hepatitis C-associated cryoglobulinaemiaJournal of Infection, 1998
- Interferon-α treatment of hepatitis C virus-associated mixed cryoglobulinemiaJournal of Hepatology, 1998
- An Algorithm for the Grading of Activity in Chronic Hepatitis CHepatology, 1996
- Membranoproliferative glomerulonephritis associated with hepatitis C virus infection responsive to interferon-αAmerican Journal of Kidney Diseases, 1995